| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 505,900 | 458,626 | 384,796 | 508,078 | | Cost of Revenue | 295,817 | 271,530 | 241,491 | 335,186 | | | Gross Profit | 210,083 | 187,096 | 143,305 | 172,892 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 114,322 | 108,655 | 97,185 | 109,698 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 95,761 | 78,441 | 46,120 | 63,194 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,817 | 939 | 2,091 | 2,953 | | Earnings Before Interest And Taxes | 97,578 | 79,380 | 48,211 | 66,147 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 97,578 | 79,380 | 48,211 | 66,147 | | Income Tax Expense | 35,186 | 30,359 | 17,406 | 25,602 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 62,392 | 49,021 | 30,805 | 40,545 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 62,392 | 49,021 | 30,805 | 40,545 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $62,392 | $49,021 | $30,805 | $40,545 |
|
0.51% Nasdaq 
Income Statement
